News

Novavax makes the nation’s only traditional protein-based coronavirus vaccine – and until now it had emergency authorization ...
After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...
(Reuters) -Novavax shares surged more than 17% before the bell on Monday, following the long-delayed approval of its COVID-19 ...
Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental The U.S. Food and Drug Administration (FDA) ...
The U.S. Food and Drug Administration approved Novavax's COVIDd-19 vaccine with age restrictions after a six-week delay.
This vaccine did previously have emergency approval by the FDA for use but can now be marketed in the U.S. for use, the ...
While the clearance is only for use in certain groups, Novavax’s long-awaited OK is still seen by analysts as a “win” for the ...
Adults over the age of 60 are recommended not to get the chikungunya vaccine to prevent the mosquito-borne illness due to two ...
The U.S. Food and Drug Administration approved Novavax’s Covid-19 vaccine, but limited its use to older adults and people over the age of 12 with conditions that put them at risk due to the illness.
The head of the Food and Drug Administration said the agency will soon unveil a new framework detailing what companies must ...
A top agency official is meeting with industry and FDA staff as he works on guidance clarifying the FDA’s expectations for ...